Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
ETON
#2570
Eton Pharmaceutcials, Inc. Common Stock
16.9
9
-0.93%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-0.93%
Monthly Change
+13.04%
6 month change
-2.80%
Year Change
+13.12%
Previous Close
17.1
5
Open
16.9
9
Bid
Ask
Low
16.9
9
High
16.9
9
Volume
47
Markets
US Stock Market
Healthcare
ETON
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
News
FDA-Zulassung für DESMODA: Eton Pharmaceuticals zielt auf Markt für Diabetes insipidus
DESMODA oral solution receives FDA approval for diabetes insipidus
Lizenz-Deal für Medikament beflügelt Eton Pharmaceuticals-Aktie
Eton Pharmaceuticals stock rises after licensing ultra-rare disease drug
Eton Pharmaceuticals lizenziert Wirkstoffkandidaten für extrem seltene Krankheit
Eton Pharmaceuticals licenses ultra-rare disease treatment candidate
Implied Volatility Surging for Eton Pharmaceuticals Stock Options
Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Beats Revenue Estimates
Eton Pharmaceuticals: EPS verfehlt Schätzungen um 0,07 $ - Umsatz besser als erwartet
Eton Pharmaceuticals earnings missed by $0.07, revenue topped estimates
Airbnb, Monster Beverage, Take-Two and more set to report earnings Thursday
Eton Stock Has Focused Growth But Valuation Limits Upside: Why I Choose To Hold